Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Dec. 9, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 9, 2013

Eisai, Emergent BioSolutions, Gilead, Helsinn, Merck Serono, Novartis, QLT

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II
Cyclacel posts MDS trial results . . . read more

Emergent gets positive results in CLL trial . . . read more

QLT doses first IDA patient . . . read more

Phase III
Merck Serono publishes data for NSCLC trial . . . read more

Filings
Helsinn, Eisai CINV treatment to be reviewed . . . read more

Approvals
Gilead’s HCV treatment approved . . . read more

Health Canada approves Novartis meningitis vaccine . . . read more

Post-Approval
Five-year data support Novartis’ Tasigna in CML . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics